Related Experiment Video
Updated: Jun 27, 2026
11:56
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Covalent Inhibitors in Antimicrobial Drug Development-Beyond β-Lactams.
Ghazaleh Jafari1, Dustin Duncan1
1Department of Chemistry, Brock University, St. Catharines, ON L2S 3A1, Canada.
Molecules (Basel, Switzerland)
|June 26, 2026
Summary
Covalent antimicrobial drugs, including non-β-lactam agents, offer broad applications but pose safety risks from off-target effects. This review details their design, mechanisms, and strategies to mitigate side effects for safer antimicrobial therapies.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Microbiology
Background:
- Covalent inhibitors have been crucial antimicrobial drugs for nearly a century, starting with penicillin.
- The β-lactam ring is a well-known reactive warhead in many successful antibiotics.
- Non-β-lactam covalent agents have expanded antimicrobial applications to fungi, parasites, and viruses.
Purpose of the Study:
- To provide a comprehensive overview of non-β-lactam covalent antimicrobials.
- To organize these agents by warhead class, mechanism of action, and resistance.
- To outline strategies for designing safer covalent drugs and mitigating clinical side effects.
Main Methods:
- Literature review of non-β-lactam covalent antimicrobials.
- Analysis of drug design, warhead classification, and resistance mechanisms.
- Examination of safety concerns and mitigation strategies for covalent adducts.
Main Results:
- Non-β-lactam covalent antimicrobials target diverse pathogen classes.
- Understanding warhead reactivity and resistance is key to drug development.
- Off-target covalent adducts remain a significant safety concern.
Conclusions:
- Covalent antimicrobials, particularly non-β-lactam types, are vital but require careful design to manage safety.
- Technological advancements enable intentional design of modern covalent drugs.
- Mitigation strategies are essential for the clinical success of covalent antimicrobial therapies.
Related Concept Videos
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:23Antimicrobial Proteins
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
01:28Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...